Spike Protein News and Research

RSS
SARS-CoV-2 spike protein shows slow but stable evolution, study finds

SARS-CoV-2 spike protein shows slow but stable evolution, study finds

Monoclonal antibody HB27 shows potent neutralizing activity against SARS-CoV-2

Monoclonal antibody HB27 shows potent neutralizing activity against SARS-CoV-2

N439K mutation of SARS-CoV-2 may be more infectious and antibody resistant than Wuhan strain

N439K mutation of SARS-CoV-2 may be more infectious and antibody resistant than Wuhan strain

Siemens Healthineers SARS-CoV-2 IgG antibody test demonstrates ability to detect neutralizing antibodies

Siemens Healthineers SARS-CoV-2 IgG antibody test demonstrates ability to detect neutralizing antibodies

Transgenic mouse model could recapitulate severe COVID-19 in humans

Transgenic mouse model could recapitulate severe COVID-19 in humans

Antihypertensive drugs may reduce COVID-19 mortality in at-risk patients

Antihypertensive drugs may reduce COVID-19 mortality in at-risk patients

Early interferon therapy may mitigate COVID-19 severity

Early interferon therapy may mitigate COVID-19 severity

Specific SARS-CoV-2 genomic variations are associated with higher COVID-19 deaths

Specific SARS-CoV-2 genomic variations are associated with higher COVID-19 deaths

Inhibiting SARS-CoV-2 cell entry with monoclonal antibodies against staphylococcal enterotoxin B superantigen

Inhibiting SARS-CoV-2 cell entry with monoclonal antibodies against staphylococcal enterotoxin B superantigen

Study: None of the SARS-CoV-2 mutations appear to increase transmissibility in humans

Study: None of the SARS-CoV-2 mutations appear to increase transmissibility in humans

SARS-CoV-2 spike protein antibodies can persist up to 200 days after symptom onset

SARS-CoV-2 spike protein antibodies can persist up to 200 days after symptom onset

Austrian study shows robust antibody response to SARS-CoV-2 for over 6 months

Austrian study shows robust antibody response to SARS-CoV-2 for over 6 months

Mefloquine shows potential as anti-SARS-CoV-2 drug

Mefloquine shows potential as anti-SARS-CoV-2 drug

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Avacta Group announces significant progress in the development of SARS-CoV-2 rapid antigen test

Avacta Group announces significant progress in the development of SARS-CoV-2 rapid antigen test

Study: Aprotinin can inhibit virus replication by preventing SARS-CoV2 entry into host cells

Study: Aprotinin can inhibit virus replication by preventing SARS-CoV2 entry into host cells

COVID-19: HLA class I genotypes and mortality

COVID-19: HLA class I genotypes and mortality

SARS-CoV-2's spike protein mutations have slowed, study finds

SARS-CoV-2's spike protein mutations have slowed, study finds

SARS-CoV-2 spike deletion mutations may evade current vaccine candidates, study finds

SARS-CoV-2 spike deletion mutations may evade current vaccine candidates, study finds

Nasal dryness could be an early warning sign of COVID-19

Nasal dryness could be an early warning sign of COVID-19